Cargando…
A 57-year-old man who developed arthritis during R-CHOP chemotherapy for non-Hodgkin lymphoma
Rituximab is a chimeric human-mouse anti-CD20 monoclonal antibody, which is used in the treatment of both B-cell lymphomas and rheumatic diseases. We describe a case of a previously healthy 57-year-old man developing arthritis while being treated with rituximab-CHOP chemotherapy (R-CHOP) for a non-H...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2262146/ https://www.ncbi.nlm.nih.gov/pubmed/17660934 http://dx.doi.org/10.1007/s10067-007-0704-0 |